Publications

​​

2024

"CRISPR-based editing strategies to rectify EYA1 complex genomic rearrangement linked to haploinsufficiency." (2024)  MOLECULAR THERAPY NUCLEIC ACIDS.  35,  2

"Precise editing of pathogenic nucleotide repeat expansions in iPSCs using paired prime editor."  (2024)  NUCLEIC ACIDS RESEARCH.  52,  10

​

2023

"Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis." (2023) CELLULAR & MOLECULAR IMMUNOLOGY.  20,  12

"β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4." (2023)  CELL DEATH & DISEASE.  14,  7

"FFAR2 antagonizes TLR2-and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-kappa B." (2023)  CELL AND BIOSCIENCE.  13,  1

 "DNA double-strand break-free CRISPR interference delays Huntington’s disease progression in mice."  (2023) COMMUNICATIONS BIOLOGY.  6,  1

 "Targeted genomic translocations and inversions generated using a paired prime editing strategy."  (2023) MOLECULAR THERAPY.  31,  1

​

2022

"Targeted genomic translocations and inversions generated using a paired prime editing strategy" MOLECULAR THERAPY (2022)

"Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations" MOLECULAR THERAPY NUCLEIC ACIDS (2022)

​​​

​

2015~2020

1. D. Kim et al., Unbiased investigation of specificities of prime editing systems in human cells NAR (2020) IF: 11.5
2. D. Kim et al., Genome-wide specificity of dCpf1 cytidine base editors. Nature communications (2020) IF: 12.1
3. D. Kim et al., Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases. Annual Review of Biochemistry (2019) IF: 30.3
4. D. Kim et al., Genome-wide target specificity of CRISPR RNA-guided adenine base editors. Nature Biotechnology (2019) IF: 31.9
5. D. Kim et al., Genome-wide target specificities of CRISPR RNA-guided programmable deaminases. Nature Biotechnology 35, 475-480 (2017) IF: 31.9
6. D. Kim et al., Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nature Biotechnology 34, 863-868 (2016) IF: 31.9 

7. D. Kim et al., Digenome-seq: Genome-wide Profiling of CRISPR-Cas9 Off-target Effects in Human Cells. Nature Methods 12, 237-243 (2015) IF: 28.5

​